BORDI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 2.665
EU - Europa 2.153
AS - Asia 2.102
SA - Sud America 322
AF - Africa 118
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.364
Nazione #
US - Stati Uniti d'America 2.590
SG - Singapore 835
CN - Cina 807
FI - Finlandia 579
SE - Svezia 367
IE - Irlanda 328
DE - Germania 281
BR - Brasile 255
UA - Ucraina 210
HK - Hong Kong 170
IT - Italia 127
TR - Turchia 97
VN - Vietnam 88
NL - Olanda 77
GB - Regno Unito 69
ZA - Sudafrica 69
CA - Canada 57
CI - Costa d'Avorio 33
BE - Belgio 29
AR - Argentina 25
IN - India 25
RU - Federazione Russa 22
BD - Bangladesh 14
EC - Ecuador 14
PL - Polonia 14
FR - Francia 13
JP - Giappone 13
MX - Messico 10
CZ - Repubblica Ceca 8
ES - Italia 8
IQ - Iraq 6
MA - Marocco 6
KR - Corea 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
VE - Venezuela 5
AT - Austria 4
AZ - Azerbaigian 4
BO - Bolivia 4
BY - Bielorussia 4
ID - Indonesia 4
IR - Iran 4
PY - Paraguay 4
UZ - Uzbekistan 4
CL - Cile 3
CO - Colombia 3
JO - Giordania 3
NP - Nepal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
PA - Panama 2
SA - Arabia Saudita 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
CH - Svizzera 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TV - Tuvalu 1
Totale 7.364
Città #
Singapore 380
Chandler 337
Dublin 328
Ashburn 300
Jacksonville 284
Beijing 206
Santa Clara 186
Hong Kong 170
Ann Arbor 159
Dearborn 129
Dallas 126
Nanjing 104
Izmir 90
Boardman 82
New York 82
Munich 68
Johannesburg 63
Princeton 63
Shanghai 62
Los Angeles 56
San Mateo 56
Toronto 44
Parma 43
Helsinki 39
Wilmington 38
Ho Chi Minh City 36
Shenyang 35
Abidjan 33
Hefei 33
Bremen 32
Nanchang 32
Turku 31
Brussels 29
Kunming 29
Hebei 27
Jinan 26
Des Moines 22
Grafing 22
Columbus 20
São Paulo 20
Hanoi 18
Tianjin 18
Buffalo 17
Guangzhou 15
London 15
Frankfurt am Main 14
Changsha 13
Moscow 13
Tokyo 13
Brooklyn 11
The Dalles 11
Warsaw 10
Woodbridge 9
Zhengzhou 9
Haiphong 8
Seattle 8
Augusta 7
Jiaxing 7
Norwalk 7
Phoenix 7
Pune 7
Stockholm 7
Taiyuan 7
Denver 6
Falkenstein 6
Fuzhou 6
Haikou 6
Milan 6
Mordano 6
Redondo Beach 6
Rio de Janeiro 6
San Francisco 6
Amsterdam 5
Bexley 5
Chengdu 5
Council Bluffs 5
Curitiba 5
Düsseldorf 5
Genoa 5
Montreal 5
Quito 5
Wuhan 5
Atlanta 4
Auburn Hills 4
Belo Horizonte 4
Brno 4
Campinas 4
Chennai 4
Guayaquil 4
Hangzhou 4
Houston 4
Mumbai 4
Ningbo 4
Porto Alegre 4
Ribeirão das Neves 4
Wroclaw 4
Amman 3
Ananindeua 3
Ankara 3
Baku 3
Totale 4.345
Nome #
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 189
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 186
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 162
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 160
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 158
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 157
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 156
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 152
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 149
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 148
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 146
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 138
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 138
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 138
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 137
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 134
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 133
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 128
Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long-a and short-term administration 125
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 124
Functional Studies of New Imidazole H3-Antagonists on Guinea-Pig Isolated Preparations 123
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 123
Are histamine receptors involved in the stimulant activities of thiazolylethylamines supposed as cyclic models of dimaprit? 123
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 121
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 120
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 119
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 119
Structural researcheson H^-agonists: the structures of the dipicrates of 2-(2-amino-4-imidazolyl)ethylamine, its 5-methyl derivative and N^f-dimeihyl-2-(2-am'mo-l,3-thiazol-5-yl)ethylamine 115
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 115
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 113
Irreversible EGFR inhibitor compounds with antiproliferative activity 112
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 112
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 111
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 110
Action of histamine and of different synthetic H2 receptor stimulants on the isolated gastric fundus of the guinea pig 109
A possible physiological role of histamine H2-receptors in rat mesenteric circulation 108
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 108
Plasma concentration and brain penetration of the H3-receptor antagonist Thioperamide in rats 106
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 106
Antipyretic activity of new compounds "4-(3-OXO-1,2-BENZISOTHIAZOLIN-2-YL) PHENYLALKANOIC acids, their esters, amides and 1,1-dioxide derivatives 100
Auxin-like activity of 1,2-benzisothiazole derivatives 99
Ligands for the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type 98
Pharmacological activities of two new histamine analogs 98
H3-receptor antagonists: Synthesis and structure relationships of para- and meta-substituted 4(5)-phenyl-2-((2-(4(5)-imidazolyl)ethyl)thio)imidazoles 98
In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated derivatives 98
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 96
Sviluppo e caratterizzazione farmacologica di un nuovo potente e selettivo H3-bloccante istaminico non-tioureico 96
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 96
QSAR study on H3-receptor affinity of benzothiazole derivatives of thioperamide 96
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 95
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 93
Pharmacological profile of original potent H3 receptor antagonists 92
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 89
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 89
Pharmacological profile of new thioperamide derivatives at histamine peripheral H1-, H2, H3-receptors in guinea-pig 87
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 87
Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain 86
Synthesis and binding assays of H3-receptor ligands. 82
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 77
Melatonin Receptor Ligands: Synthesis of New Melatonin Derivatives and Comprehensive Comparative Molecular Field Analysis (CoMFA) Study. 70
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 62
null 61
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H2-receptor antagonist activity in gastric fistula cat. 59
THIAZOLYLALKYLAMINES - SYNTHESIS OF ANALOGS OF IMIDAZOLYLETHYLAMINES AND THEIR INFLUENCE ON GASTRIC-SECRETION 59
Pharmacological activities of two new histamine analogs 55
null 37
Totale 7.386
Categoria #
all - tutte 26.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 2 59 5 101 8 91 2
2021/2022344 7 3 3 30 17 33 45 49 19 24 21 93
2022/20231.308 156 143 89 86 121 162 18 74 411 10 30 8
2023/2024410 22 45 3 10 31 137 39 17 14 19 27 46
2024/20251.468 51 78 89 93 105 183 42 60 197 144 132 294
2025/20261.631 276 300 287 291 433 44 0 0 0 0 0 0
Totale 7.386